Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Roche is my take as our NMIBC jv partner

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Mar 07, 2023 10:42am

412 Views

Post# 35323606

Roche is my take as our NMIBC jv partner

Pfizer and Merck seem to have other plans. At least, for what we've seen in their strategic plans recently announced. Doesn't mean the door is completely closed though.

Roche has failed in entering the bladder cancer indication. They would have a golden opportunity to re-enter this important market.

Roche is also in the 3 fields that we're aiming; urology, neurology and pulmonary.

Roche is bigger than Pfizer and Merck.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments